title: Inflammatory bowel disease: Part II. Medical and surgical management.
abstract: Substantial advances have been made in the management of inflammatory bowel disease. Mesalamine and olsalazine are new anti-inflammatory agents that may serve as alternatives to corticosteroids and sulfasalazine, which have been the mainstays of medical therapy. These new agents are available in oral, enema and suppository forms. Brooke ileostomy remains the standard surgical treatment for advanced ulcerative pancolitis, but continent ileostomy procedures may be more cosmetically acceptable to selected patients.
authors.affiliation: University of Kansas School of Medicine-Wichita.
authors.forename: G E
authors.initials: GE
authors.lastname: Hastings
authors.forename: R J
authors.initials: RJ
authors.lastname: Weber
mesh_terms: D003093:Colitis, Ulcerative / Q000628:therapy; D003424:Crohn Disease / Q000628:therapy; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000601:surgery* / Q000628:therapy*; D008532:Megacolon, Toxic / Q000628:therapy; D011379:Prognosis